The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March

Core Insights - The Oncology Institute, Inc. (NASDAQ: TOI) is participating in several investor conferences in March 2026, showcasing its commitment to engaging with investors and stakeholders [1][3]. Company Overview - Founded in 2007, The Oncology Institute specializes in value-based cancer care, serving approximately 1.9 million patients with advanced, evidence-based treatment options [2]. - The company operates over 100 clinics and affiliate locations across five states, employing more than 180 clinicians, which positions it as a significant player in community oncology [2]. Upcoming Conferences - The company will present at the Jefferies Healthcare Services Innovation & Technology Summit on March 9, 2026, featuring CEO Dr. Daniel Virnich [3]. - Additionally, a presentation at the Leerink Global Healthcare Conference will occur on the same day, with CFO Rob Carter as the presenter [3]. - The Oppenheimer 36th Annual Healthcare MedTech & Services Conference will take place on March 16, 2026, with both Dr. Daniel Virnich and Rob Carter presenting [3].